Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

O’Brien, 2009, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates, Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6

World Health Organization, 2012, Pneumococcal vaccines: WHO position paper-2012-recommendations, Vaccine, 30, 4717, 10.1016/j.vaccine.2012.04.093

Novaes, 2011, Hospitalization rates for pneumococcal disease in Brazil, 2004–2006, Rev Saúde Públ, 45, 539, 10.1590/S0034-89102011005000028

Azevedo, 2013, Bacterial meningitis in Brazil: baseline epidemiologic assessment of the decade prior to the introduction of pneumococcal and meningococcal vaccines, PLOS ONE, 8, e64524, 10.1371/journal.pone.0064524

Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823

Kaplan, 2010, Serotype 19A is the most common serotype causing invasive pneumococcal infections in children, Pediatrics, 125, 429, 10.1542/peds.2008-1702

Gladstone, 2011, Continued control of pneumococcal disease in the UK – the impact of vaccination, J Med Microbiol, 60, 1, 10.1099/jmm.0.020016-0

Brasil, Ministério da Saúde Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, 2006

Brasil, Ministério da Saúde Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, 2010

Santos, 2013, Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation, Vaccine, 31, 6150, 10.1016/j.vaccine.2013.05.042

Afonso, 2013, Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil, Emerg Infect Dis, 19, 589, 10.3201/eid1904.121198

Hausdorff, 2000, Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, Part I, Clin Infect Dis, 30, 100, 10.1086/313608

Lovgren, 2007, Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae: developed for the SIREVA Project in Latin America, from 1993 to 2005, J Clin Microbiol, 45, 3184, 10.1128/JCM.00789-07

da Gloria Carvalho, 2010, Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes, J Clin Microbiol, 48, 1611, 10.1128/JCM.02243-09

Centers for Disease Control Prevention (CDC), 2014

Carvalho, 2009, PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007, J Clin Microbiol, 47, 554, 10.1128/JCM.01919-08

Nascimento-Carvalho, 2006, Cepas invasivas de pneumococo isoladas de crianças e adolescentes em Salvador, J Pediatr (Rio J), 79, 209, 10.1590/S0021-75572003000300005

Castañeda, 2009, Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000–2005, Pediatr Infect Dis J, 28, e265, 10.1097/INF.0b013e3181a74b22

Brasil, Ministério da Saúde Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, 2009

Menezes, 2011, Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000–2007, Vaccine, 29, 1139, 10.1016/j.vaccine.2010.12.021

Vesikari, 2009, Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine, Pediatr Infect Dis J, 28, S66, 10.1097/INF.0b013e318199f8ef

Finland, 1977, Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974, J Clin Microbiol, 5, 154, 10.1128/jcm.5.2.154-166.1977

Mott, 2007, Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil, Int J Infect Dis, 20, 47, 10.1016/j.ijid.2013.11.009

Hausdorff, 2005, Epidemiological differences among pneumococcal serotypes, Lancet Infect Dis, 5, 83, 10.1016/S1473-3099(05)70083-9

Foster, 2008, Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England, J Med Microbiol, 57, 480, 10.1099/jmm.0.47690-0